[1]
Marcellusi, A., Bini, C., Muzii, B., Soudani, S., Kieffer, A., Beuvelet, M., Bozzola, E., Midulla, F., Baraldi, E., Bonanni, P., Boccalini, S. and Orfeo, L. 2025. Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy. Global and Regional Health Technology Assessment. 12, 1 (Jan. 2025), 16–28. DOI:https://doi.org/10.33393/grhta.2025.3182.